These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25131370

  • 21. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
    Doubremelle M, Bourreille A, Zerbib F, Heresbach D, Metman EH, Beau P, Gournay J, Galmiche JP.
    Gastroenterol Clin Biol; 2002 Nov; 26(11):973-9. PubMed ID: 12483127
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [A case of generalized tuberculosis in the use of infliximab (Remicade) in patients with Bekhterev's disease].
    Nekrasov EV, Strelis AK, Ianova GV, Filiniuk OV, Buĭnova LN.
    Tuberk Biolezni Legkih; 2009 Nov; (8):56-60. PubMed ID: 19803353
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
    Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM.
    N Engl J Med; 2001 Oct 11; 345(15):1098-104. PubMed ID: 11596589
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fatal staphylococcal sepsis in Crohn's disease after infliximab.
    Herrlinger KR, Borutta A, Meinhardt G, Stange EF, Fellermann K.
    Inflamm Bowel Dis; 2004 Sep 11; 10(5):655-6. PubMed ID: 15472530
    [Abstract] [Full Text] [Related]

  • 37. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
    Feagan BG, Enns R, Fedorak RN, Panaccione R, Paré P, Steinhart AH, Wild G.
    Can J Clin Pharmacol; 2001 Sep 11; 8(4):188-98. PubMed ID: 11743591
    [Abstract] [Full Text] [Related]

  • 38. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF.
    Inflamm Bowel Dis; 2004 Jul 11; 10(4):436-7. PubMed ID: 15475754
    [Abstract] [Full Text] [Related]

  • 39. Disseminated primary varicella after initiation of infliximab for Crohn's disease.
    Leung VS, Nguyen MT, Bush TM.
    Am J Gastroenterol; 2004 Dec 11; 99(12):2503-4. PubMed ID: 15571606
    [No Abstract] [Full Text] [Related]

  • 40. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP, Kelleher B, Ramadan S, Quinlan M, Sugrue D, O'Donovan MA.
    Inflamm Bowel Dis; 2008 Mar 11; 14(3):428-9. PubMed ID: 17924565
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.